COVID-19 and obesity: the meeting of two pandemics
AUTOR(ES)
Brandão, Simone Cristina Soares; Godoi, Emmanuelle Tenório Albuquerque Madruga; Cordeiro, Lúcia Helena de Oliveira; Bezerra, Camila Silva; Ramos, Júlia de Oliveira Xavier; Arruda, Gustavo Freitas Alves de; Lins, Esdras Marques
FONTE
Arch. Endocrinol. Metab.
DATA DE PUBLICAÇÃO
2021-02
RESUMO
ABSTRACT COVID-19 and obesity are two pandemic diseases that the world is currently facing. Both activate the immune system and mediate inflammation. A sequence of disease phases in patients with severe COVID-19 results in a cytokine storm, which amplifies the subclinical inflammation that already exists in patients with obesity. Pro-inflammatory cytokines and chemotactic factors increase insulin resistance in obesity. Therefore, a greater systemic inflammatory response is establishe, along with an increased risk of thrombotic phenomena and hyperglycemic conditions. These changes further impair pulmonary, cardiac, hepatic, and renal functions, in addition to hindering glycemic control in people with diabetes and pre-diabetes. This review explains the pathophysiological mechanisms of these two pandemic diseases, provides a deeper understanding of this harmful interaction and lists possible therapeutic strategies for this risk group.
Documentos Relacionados
- What is the Role of OBGYN Residents during COVID-19 Pandemics?
- Head and Neck Practice in the COVID-19 Pandemics Today: A Rapid Systematic Review
- The impact of COVID-19 in children and adolescents with obesity in Brazil
- COVID-19 pandemics and mental health: In times like these, we learn to live again
- Two years of the COVID-19 pandemic: an anesthesiology perspective